Securities Code: 300158 Securities Abbreviation: Zhendong Pharmaceutical Announcement No.: 2026-013
Shanxi Zhendong Pharmaceutical Co., Ltd. Resolution Announcement of the 13th Meeting of the 6th Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, without false records, misleading statements, or major omissions.
I. Convening of the Board Meeting
The 13th meeting of the 6th Board of Directors of Shanxi Zhendong Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held on April 17, 2026, at 17:00 via on-site and telecommunication methods at the Company's meeting room. The meeting notice was sent to all directors on April 7, 2026, via telephone, email, and other means. A total of 9 directors were expected to attend, and 9 directors actually attended. The meeting was presided over by Mr. Li Kun, and all senior management personnel of the Company were present. The number of attendees, the convocation, the convening procedures, and the agenda of this meeting comply with the relevant laws and regulations of the state and the provisions of the "Company Articles of Association."
II. Deliberation of the Board Meeting
- The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "2025 Annual Board of Directors Work Report." The content of the "2025 Annual Board of Directors Work Report" can be found on the designated information disclosure website of the ChiNext market of the China Securities Regulatory Commission. The independent directors Lv Wanliang, Jin Linna, and Qin Xuemei have submitted their "2025 Annual Independent Director Performance Reports" to the Board, and they will present their reports at the Company's 2025 Annual Shareholders' Meeting. The content of the performance reports can be found on the designated information disclosure website of the ChiNext market of the China Securities Regulatory Commission.
The above proposal still needs to be submitted to the Company's Shareholders' Meeting for deliberation.
-
The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "<2025 Annual Report> and its Summary." The content of the "<2025 Annual Report> and its Summary" can be found on the designated information disclosure website of the ChiNext market of the China Securities Regulatory Commission. This proposal has been reviewed and approved by the Board's Audit Committee.
-
The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "2025 Annual Financial Report." The content of the "2025 Annual Financial Report" can be found on the designated information disclosure website of the ChiNext market of the China Securities Regulatory Commission. This proposal has been reviewed and approved by the Board's Audit Committee.
-
The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "2025 Annual Final Accounts Report." The content of the "2025 Annual Final Accounts Report" can be found on the designated information disclosure website of the ChiNext market of the China Securities Regulatory Commission. This proposal has been reviewed and approved by the Board's Audit Committee.
-
The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "2025 Profit Distribution Proposal." The "Special Explanation on the Company's Decision Not to Distribute Profits in 2025" can be found on the designated information disclosure website of the ChiNext market of the China Securities Regulatory Commission. This proposal still needs to be submitted to the Company's Shareholders' Meeting for deliberation.